Clinical Data Show Return to ovulationIn clinical trials, pregnancies were observed to occur as early as 7 to 14 days after removal.
Indication NEXPLANON is indicated for use by women to prevent pregnancy. Selected Safety Information (adsbygoogle = window.adsbygoogle || []).push({});CONTRAINDICATIONS
WARNINGS AND PRECAUTIONSComplications of Insertion and Removal
Changes in Menstrual Bleeding Patterns
Ectopic Pregnancies
Thrombotic and Other Vascular Events
Ovarian Cysts
Carcinoma of the Breast and Reproductive Organs
Liver Disease
Elevated Blood Pressure
Gallbladder Disease
Carbohydrate and Lipid Metabolic Effects
Depressed Mood
Return to Ovulation
Fluid Retention
Contact Lenses
Broken or Bent Implant
ADVERSE REACTIONSClinical Trial Experience
Effects of Other Drugs on Hormonal Contraceptives Substances decreasing the plasma concentrations of hormonal contraceptives and potentially diminishing the efficacy of hormonal contraceptives:
Substances increasing the plasma concentrations of hormonal contraceptives:
Human Immunodeficiency Virus (HIV)/Hepatitis C Virus (HCV) protease inhibitors and non-nucleoside reverse transcriptase inhibitors:
Effects of Hormonal Contraceptives on Other Drugs
USE IN SPECIFIC POPULATIONSPregnancy
Lactation
Pediatric Use
Overweight Women
PATIENT COUNSELING INFORMATION
Before prescribing NEXPLANON, please read the accompanying Prescribing Information. The Patient Information also is available. |